Related Experiment Video

Updated: Jul 17, 2026

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
08:53

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke

Published on: June 6, 2025

Clinical trials of neuroprotective therapies

Justin A Zivin1

  • 1University of California San Diego, La Jolla, CA 92093-0624, USA. jzivin@ucsd.edu

Stroke
|January 31, 2007
PubMed

Insights

The first neuroprotective drug for acute stroke, NXY-059, shows promise. High-dose atorvastatin is now recommended for secondary stroke prevention, improving patient care.

Area of Science:

  • Neurology
  • Pharmacology
  • Clinical Trials

Background:

  • Numerous past failures in acute stroke therapy highlight the need for effective treatments.
  • The development of neuroprotective drugs has been a long-standing challenge in stroke research.

Purpose of the Study:

  • To report the full results of a large clinical trial on the neuroprotective drug NXY-059 for acute stroke.
  • To evaluate the safety and efficacy of high-dose atorvastatin for secondary stroke prevention.

Main Methods:

  • A large-scale clinical trial was conducted to assess NXY-059 in acute stroke patients.
  • Clinical data on high-dose atorvastatin use in secondary stroke prevention was analyzed.

Main Results:

  • The NXY-059 trial demonstrated preliminary efficacy and safety, suggesting a potential new acute stroke therapy.
  • High-dose atorvastatin was confirmed as safe and effective for preventing recurrent strokes.

Conclusions:

  • NXY-059, if confirmed, represents a significant advancement in acute stroke treatment and neuroprotective drug development.
  • High-dose atorvastatin should be integrated into standard care for stroke patients to prevent secondary events.

More Related Videos

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia10:13

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia

Published on: July 31, 2017

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...